#METABOLOMICS WORKBENCH metabolic_charlie_20220511_212306 DATATRACK_ID:3244 STUDY_ID:ST002163 ANALYSIS_ID:AN003545 PROJECT_ID:PR001376 VERSION 1 CREATED_ON May 13, 2022, 7:22 am #PROJECT PR:PROJECT_TITLE Remote solid cancers rewire hepatic nitrogen metabolism via host PR:PROJECT_TITLE nicotinamide-N-methyltransferase PR:PROJECT_SUMMARY Cancers disrupt host homeostasis in various manners but the identity of host PR:PROJECT_SUMMARY factors underlying such disruption remains largely unknown. Here we show that PR:PROJECT_SUMMARY nicotinamide-N-methyltransferase (NNMT) is a novel host factor that mediates PR:PROJECT_SUMMARY metabolic dysfunction in the livers of cancer-bearing mice. Multiple solid PR:PROJECT_SUMMARY cancers distantly increase expression of Nnmt and its product PR:PROJECT_SUMMARY 1-methylnicotinamide (MNAM) in the liver. Multi-omics analyses reveal PR:PROJECT_SUMMARY suppression of the urea cycle accompanied by accumulation of amino acids, and PR:PROJECT_SUMMARY enhancement of uracil biogenesis in the livers of cancer-bearing mice. PR:PROJECT_SUMMARY Importantly, genetic deletion of Nnmt leads to alleviation of these metabolic PR:PROJECT_SUMMARY abnormalities, and buffers cancer-dependent weight loss and reduction of the PR:PROJECT_SUMMARY voluntary wheel-running activity. Our data also demonstrate that MNAM is capable PR:PROJECT_SUMMARY of affecting urea cycle metabolites in the liver. These results suggest that PR:PROJECT_SUMMARY cancers up-regulate the hepatic NNMT pathway to rewire liver metabolism towards PR:PROJECT_SUMMARY uracil biogenesis rather than nitrogen disposal via the urea cycle, thereby PR:PROJECT_SUMMARY disrupting host homeostasis. PR:INSTITUTE Tohoku University PR:LAST_NAME Kawaoka PR:FIRST_NAME Shinpei PR:ADDRESS 4-1 Seiryo-cho, Sendai, Miyagi, 9808575, Japan PR:EMAIL kawaokashinpei@gmail.com PR:PHONE 0227178568 #STUDY ST:STUDY_TITLE Remote solid cancers rewire hepatic nitrogen metabolism via host ST:STUDY_TITLE nicotinamide-N-methyltransferase ST:STUDY_SUMMARY Cancers disrupt host homeostasis in various manners but the identity of host ST:STUDY_SUMMARY factors underlying such disruption remains largely unknown. Here we show that ST:STUDY_SUMMARY nicotinamide-N-methyltransferase (NNMT) is a novel host factor that mediates ST:STUDY_SUMMARY metabolic dysfunction in the livers of cancer-bearing mice. Multiple solid ST:STUDY_SUMMARY cancers distantly increase expression of Nnmt and its product ST:STUDY_SUMMARY 1-methylnicotinamide (MNAM) in the liver. Multi-omics analyses reveal ST:STUDY_SUMMARY suppression of the urea cycle accompanied by accumulation of amino acids, and ST:STUDY_SUMMARY enhancement of uracil biogenesis in the livers of cancer-bearing mice. ST:STUDY_SUMMARY Importantly, genetic deletion of Nnmt leads to alleviation of these metabolic ST:STUDY_SUMMARY abnormalities, and buffers cancer-dependent weight loss and reduction of the ST:STUDY_SUMMARY voluntary wheel-running activity. Our data also demonstrate that MNAM is capable ST:STUDY_SUMMARY of affecting urea cycle metabolites in the liver. These results suggest that ST:STUDY_SUMMARY cancers up-regulate the hepatic NNMT pathway to rewire liver metabolism towards ST:STUDY_SUMMARY uracil biogenesis rather than nitrogen disposal via the urea cycle, thereby ST:STUDY_SUMMARY disrupting host homeostasis. Anionic polar metabolites (i.e., organic acids, ST:STUDY_SUMMARY sugar phosphates, nucleotides,etc.) were analyzed via IC/HR/MS/MS. Cationic ST:STUDY_SUMMARY polar metabolites (i.e., amino acids, bases, nucleosides, NAM, SAM, MNAM, SAH, ST:STUDY_SUMMARY me2PY, me4PY, etc) were analyzed via PFPP-LC/HR/MS/MS. ST:INSTITUTE Tohoku University ST:LAST_NAME Kawaoka ST:FIRST_NAME Shinpei ST:ADDRESS 4-1, Seiryou-machi, Aoba-ku, Sendai ST:EMAIL kawaokashinpei@gmail.com ST:PHONE 0227178443 #SUBJECT SU:SUBJECT_TYPE Mammal SU:SUBJECT_SPECIES Mus musculus SU:TAXONOMY_ID 10090 #FACTORS #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS 190428 L1 Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L1 SUBJECT_SAMPLE_FACTORS 190428 L2 Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L2 SUBJECT_SAMPLE_FACTORS 190428 L3 Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L3 SUBJECT_SAMPLE_FACTORS 190428 L4 Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L4 SUBJECT_SAMPLE_FACTORS 190428 L49 Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L49 SUBJECT_SAMPLE_FACTORS 190428 L5 Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L5 SUBJECT_SAMPLE_FACTORS 190428 L6 Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L6 SUBJECT_SAMPLE_FACTORS 190428 L7 Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L7 SUBJECT_SAMPLE_FACTORS 190428 L8 Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L8 SUBJECT_SAMPLE_FACTORS 190428 L50 Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L50 SUBJECT_SAMPLE_FACTORS 190428 L9 Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L9 SUBJECT_SAMPLE_FACTORS 190428 L10 Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L10 SUBJECT_SAMPLE_FACTORS 190428 L11 Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L11 SUBJECT_SAMPLE_FACTORS 190428 L12 Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L12 SUBJECT_SAMPLE_FACTORS 190428 L52 Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L52 SUBJECT_SAMPLE_FACTORS 190428 L13 Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L13 SUBJECT_SAMPLE_FACTORS 190428 L14 Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L14 SUBJECT_SAMPLE_FACTORS 190428 L15 Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L15 SUBJECT_SAMPLE_FACTORS 190428 L16 Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L16 SUBJECT_SAMPLE_FACTORS 190428 L51 Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L51 SUBJECT_SAMPLE_FACTORS 201215 L1_MNAM Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L1_MNAM SUBJECT_SAMPLE_FACTORS 201215 L2_MNAM Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L2_MNAM SUBJECT_SAMPLE_FACTORS 201215 L3_MNAM Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L3_MNAM SUBJECT_SAMPLE_FACTORS 201215 L4_MNAM Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment RAW_FILE_NAME=L4_MNAM SUBJECT_SAMPLE_FACTORS 201215 L5_MNAM Genotype:WT | Sample group:Sham | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L5_MNAM SUBJECT_SAMPLE_FACTORS 201215 L6_MNAM Genotype:WT | Sample group:Sham | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L6_MNAM SUBJECT_SAMPLE_FACTORS 201215 L7_MNAM Genotype:WT | Sample group:Sham | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L7_MNAM SUBJECT_SAMPLE_FACTORS 201215 L8_MNAM Genotype:WT | Sample group:Sham | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L8_MNAM SUBJECT_SAMPLE_FACTORS 201215 L9_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L9_MNAM SUBJECT_SAMPLE_FACTORS 201215 L10_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L10_MNAM SUBJECT_SAMPLE_FACTORS 201215 L11_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L11_MNAM SUBJECT_SAMPLE_FACTORS 201215 L12_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment RAW_FILE_NAME=L12_MNAM SUBJECT_SAMPLE_FACTORS 201215 L13_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L13_MNAM SUBJECT_SAMPLE_FACTORS 201215 L14_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L14_MNAM SUBJECT_SAMPLE_FACTORS 201215 L15_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L15_MNAM SUBJECT_SAMPLE_FACTORS 201215 L16_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L16_MNAM SUBJECT_SAMPLE_FACTORS 201215 L17_MNAM Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment RAW_FILE_NAME=L17_MNAM #COLLECTION CO:COLLECTION_SUMMARY Mouse livers were crushed in liquid-nitrogen and homogenized. CO:SAMPLE_TYPE Liver #TREATMENT TR:TREATMENT_SUMMARY Daily 250 mg/kg MNAM injection for 12 days in the absence (sham) and presence TR:TREATMENT_SUMMARY (4T1cancers). #SAMPLEPREP SP:SAMPLEPREP_SUMMARY Metabolites were extracted from the frozen livers (approximately 5 mg) using the SP:SAMPLEPREP_SUMMARY Bligh and Dyer’s method with some modifications. Briefly, each sample was SP:SAMPLEPREP_SUMMARY mixed with 1 mL of cold methanol containing 10-camphorsulfonic acid (1.5 nmol) SP:SAMPLEPREP_SUMMARY and piperazine-1,4-bis (2-ethanesulfonic acid) (PIPES, 1.5 nmol) as internal SP:SAMPLEPREP_SUMMARY standards for mass spectrometry-based metabolomic analysis. The samples were SP:SAMPLEPREP_SUMMARY vigorously mixed by vortexing for 1 min followed by 5 min of sonication. The SP:SAMPLEPREP_SUMMARY extracts were then centrifuged at 16,000 × g for 5 min at 4 °C, and the SP:SAMPLEPREP_SUMMARY resultant supernatant (400 uL) was collected. After mixing 400 uL of supernatant SP:SAMPLEPREP_SUMMARY with 400 uL of chloroform and 320 uL of water, the aqueous and organic layers SP:SAMPLEPREP_SUMMARY were separated by vortexing and subsequent centrifugation at 16,000 × g and 4 SP:SAMPLEPREP_SUMMARY °C for 5 min. The aqueous (upper) layer (500 uL) was transferred into a clean SP:SAMPLEPREP_SUMMARY tube. After the aqueous layer extracts were evaporated under vacuum, the dried SP:SAMPLEPREP_SUMMARY extracts were stored at −80 °C until the analysis of hydrophilic metabolites. SP:SAMPLEPREP_SUMMARY Prior to analysis, the dried aqueous layer was reconstituted in 50 uL of water. #CHROMATOGRAPHY CH:CHROMATOGRAPHY_SUMMARY Cationic polar metabolites (i.e., amino acids, bases, nucleosides, NAM, SAM, CH:CHROMATOGRAPHY_SUMMARY MNAM, SAH, me2PY, me4PY, etc) were analyzed via PFPP-LC/HRMS/MS. CH:CHROMATOGRAPHY_TYPE Reversed phase CH:INSTRUMENT_NAME Shimadzu Nexera X2 CH:COLUMN_NAME Discovery HS (2.1 mm i.d. × 150 mm, 3 um particle size, Merck) #ANALYSIS AN:ANALYSIS_TYPE MS AN:LABORATORY_NAME Bamba lab. AN:OPERATOR_NAME Masatomo Takahashi #MS MS:INSTRUMENT_NAME Thermo Q Exactive Orbitrap MS:INSTRUMENT_TYPE Orbitrap MS:MS_TYPE ESI MS:ION_MODE POSITIVE MS:MS_COMMENTS - #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS peak area MS_METABOLITE_DATA_START Samples L1 L2 L3 L4 L49 L5 L6 L7 L8 L50 L9 L10 L11 L12 L52 L13 L14 L15 L16 L51 L1_MNAM L2_MNAM L3_MNAM L4_MNAM L5_MNAM L6_MNAM L7_MNAM L8_MNAM L9_MNAM L10_MNAM L11_MNAM L12_MNAM L13_MNAM L14_MNAM L15_MNAM L16_MNAM L17_MNAM Factors Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:NNMT KO | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:No treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:MNAM treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:MNAM treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:MNAM treatment Genotype:WT | Sample group:Sham | Sex:female | Treatment:MNAM treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:No treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment Genotype:WT | Sample group:4T1 | Sex:female | Treatment:MNAM treatment 10-Camphorsulfonic acid (IS) 2.E+07 2.E+07 2.E+07 2.E+07 2.E+07 1.E+07 1.E+07 2.E+07 1.E+07 1.E+07 1.E+07 1.E+07 2.E+07 2.E+07 2.E+07 2.E+07 2.E+07 2.E+07 2.E+07 1.E+07 4.E+07 5.E+07 4.E+07 4.E+07 3.E+07 3.E+07 3.E+07 4.E+07 4.E+07 3.E+07 3.E+07 3.E+07 3.E+07 3.E+07 3.E+07 3.E+07 3.E+07 PIPES (IS) 5.E+07 6.E+07 4.E+07 5.E+07 5.E+07 3.E+07 3.E+07 4.E+07 3.E+07 3.E+07 3.E+07 3.E+07 4.E+07 4.E+07 3.E+07 5.E+07 5.E+07 5.E+07 4.E+07 3.E+07 8.E+07 9.E+07 9.E+07 8.E+07 7.E+07 8.E+07 6.E+07 8.E+07 8.E+07 7.E+07 7.E+07 6.E+07 6.E+07 6.E+07 6.E+07 6.E+07 6.E+07 NAD 3.E+07 3.E+07 2.E+07 3.E+07 3.E+07 1.E+07 2.E+07 2.E+07 1.E+07 1.E+07 2.E+07 3.E+07 4.E+07 3.E+07 3.E+07 2.E+07 2.E+07 2.E+07 1.E+07 2.E+07 - - - - - - - - - - - - - - - - - Suc 5.E+07 5.E+07 2.E+07 5.E+07 6.E+07 3.E+07 3.E+07 4.E+07 5.E+07 4.E+07 1.E+07 4.E+07 4.E+07 4.E+07 4.E+07 4.E+07 5.E+07 8.E+07 4.E+07 4.E+07 - - - - - - - - - - - - - - - - - Adenine 3.E+07 4.E+07 3.E+07 3.E+07 3.E+07 2.E+07 2.E+07 3.E+07 2.E+07 2.E+07 2.E+07 2.E+07 3.E+07 3.E+07 3.E+07 3.E+07 3.E+07 3.E+07 2.E+07 2.E+07 - - - - - - - - - - - - - - - - - Adenosine 1.E+08 1.E+08 9.E+07 8.E+07 1.E+08 7.E+07 1.E+08 2.E+08 8.E+07 1.E+08 8.E+07 7.E+07 1.E+08 1.E+08 9.E+07 1.E+08 2.E+08 3.E+08 2.E+08 1.E+08 - - - - - - - - - - - - - - - - - Beta-Ala 2.E+07 2.E+07 1.E+07 2.E+07 3.E+07 2.E+07 3.E+07 4.E+07 3.E+07 3.E+07 1.E+07 3.E+07 4.E+07 3.E+07 2.E+07 5.E+07 4.E+07 6.E+07 4.E+07 3.E+07 2.E+08 2.E+08 2.E+08 3.E+08 2.E+08 2.E+08 2.E+08 2.E+08 3.E+08 2.E+08 3.E+08 2.E+08 2.E+08 2.E+08 2.E+08 3.E+08 3.E+08 Betaine 2.E+08 1.E+08 1.E+08 1.E+08 3.E+08 2.E+08 3.E+08 8.E+08 3.E+08 2.E+08 4.E+08 1.E+09 6.E+08 6.E+08 3.E+08 8.E+08 5.E+08 7.E+08 2.E+08 2.E+08 - - - - - - - - - - - - - - - - - Carnitine 8.E+08 7.E+08 4.E+08 5.E+08 5.E+08 4.E+08 6.E+08 7.E+08 4.E+08 5.E+08 7.E+08 8.E+08 8.E+08 8.E+08 5.E+08 8.E+08 7.E+08 8.E+08 6.E+08 4.E+08 - - - - - - - - - - - - - - - - - Carnosine 2.E+06 3.E+06 7.E+05 1.E+06 1.E+06 4.E+05 4.E+05 4.E+05 5.E+05 1.E+06 1.E+06 6.E+05 1.E+06 2.E+06 1.E+06 1.E+06 2.E+06 8.E+05 5.E+05 1.E+06 - - - - - - - - - - - - - - - - - Choline 7.E+08 7.E+08 6.E+08 5.E+08 6.E+08 6.E+08 8.E+08 9.E+08 6.E+08 7.E+08 5.E+08 5.E+08 6.E+08 8.E+08 5.E+08 1.E+09 1.E+09 1.E+09 9.E+08 9.E+08 - - - - - - - - - - - - - - - - - Creatine 5.E+08 5.E+08 3.E+08 4.E+08 4.E+08 3.E+08 4.E+08 4.E+08 4.E+08 4.E+08 3.E+08 2.E+08 4.E+08 4.E+08 3.E+08 5.E+08 5.E+08 6.E+08 5.E+08 4.E+08 - - - - - - - - - - - - - - - - - Creatinine 4.E+07 4.E+07 2.E+07 5.E+07 3.E+07 3.E+07 3.E+07 5.E+07 3.E+07 2.E+07 2.E+07 3.E+07 4.E+07 4.E+07 3.E+07 5.E+07 4.E+07 6.E+07 3.E+07 3.E+07 - - - - - - - - - - - - - - - - - Cytidine 1.E+06 1.E+06 8.E+05 1.E+06 9.E+05 2.E+06 3.E+06 5.E+06 2.E+06 2.E+06 9.E+05 8.E+05 1.E+06 1.E+06 9.E+05 3.E+06 4.E+06 6.E+06 4.E+06 2.E+06 6.E+06 2.E+07 1.E+07 6.E+06 4.E+06 5.E+06 1.E+07 6.E+06 1.E+07 7.E+06 7.E+06 7.E+06 6.E+06 6.E+06 6.E+06 8.E+06 7.E+06 Cytosine 3.E+06 4.E+06 2.E+06 4.E+06 2.E+06 2.E+06 2.E+06 3.E+06 1.E+06 2.E+06 2.E+06 3.E+06 3.E+06 2.E+06 2.E+06 3.E+06 3.E+06 3.E+06 2.E+06 2.E+06 - - - - - - - - - - - - - - - - - GABA 1.E+07 1.E+07 1.E+07 1.E+07 1.E+07 5.E+06 4.E+06 8.E+06 8.E+06 7.E+06 7.E+06 1.E+07 2.E+07 1.E+07 1.E+07 1.E+07 9.E+06 1.E+07 7.E+06 7.E+06 - - - - - - - - - - - - - - - - - Gly 6.E+07 7.E+07 3.E+07 4.E+07 8.E+07 2.E+07 4.E+07 5.E+07 3.E+07 5.E+07 4.E+07 5.E+07 8.E+07 8.E+07 5.E+07 7.E+07 8.E+07 7.E+07 5.E+07 4.E+07 - - - - - - - - - - - - - - - - - Guanine 7.E+05 2.E+06 5.E+05 6.E+05 9.E+05 5.E+05 5.E+05 9.E+05 5.E+05 7.E+05 7.E+05 8.E+05 1.E+06 9.E+05 8.E+05 1.E+06 8.E+05 9.E+05 6.E+05 8.E+05 - - - - - - - - - - - - - - - - - Guanosine 7.E+06 8.E+06 4.E+06 4.E+06 5.E+06 2.E+06 5.E+06 1.E+07 2.E+06 4.E+06 5.E+06 4.E+06 6.E+06 7.E+06 6.E+06 8.E+06 1.E+07 2.E+07 1.E+07 6.E+06 - - - - - - - - - - - - - - - - - 4-Hydroxy-Pro 1.E+07 1.E+07 6.E+06 1.E+07 3.E+07 3.E+07 2.E+07 8.E+07 3.E+07 2.E+07 2.E+07 7.E+07 4.E+07 4.E+07 1.E+07 7.E+07 4.E+07 9.E+07 3.E+07 2.E+07 - - - - - - - - - - - - - - - - - Hypoxanthine 2.E+08 2.E+08 1.E+08 2.E+08 2.E+08 1.E+08 1.E+08 2.E+08 1.E+08 2.E+08 2.E+08 1.E+08 2.E+08 2.E+08 2.E+08 2.E+08 2.E+08 2.E+08 1.E+08 2.E+08 - - - - - - - - - - - - - - - - - Ala 3.E+08 5.E+08 2.E+08 3.E+08 5.E+08 2.E+08 2.E+08 3.E+08 2.E+08 3.E+08 2.E+08 4.E+08 5.E+08 4.E+08 3.E+08 5.E+08 4.E+08 5.E+08 3.E+08 2.E+08 - - - - - - - - - - - - - - - - - Arg 7.E+06 1.E+07 6.E+06 1.E+07 1.E+07 2.E+07 1.E+07 9.E+06 2.E+07 2.E+07 7.E+06 1.E+07 1.E+07 9.E+06 1.E+07 2.E+07 2.E+07 2.E+07 1.E+07 2.E+07 8.E+06 9.E+06 1.E+07 1.E+07 2.E+07 1.E+07 1.E+07 1.E+07 2.E+07 1.E+07 2.E+07 1.E+07 1.E+07 1.E+07 1.E+07 3.E+07 1.E+07 Asn 3.E+07 3.E+07 2.E+07 3.E+07 3.E+07 3.E+07 4.E+07 3.E+07 3.E+07 5.E+07 2.E+07 3.E+07 3.E+07 3.E+07 4.E+07 4.E+07 6.E+07 4.E+07 4.E+07 4.E+07 - - - - - - - - - - - - - - - - - Asp 2.E+08 1.E+08 7.E+07 1.E+08 1.E+08 1.E+08 1.E+08 1.E+08 1.E+08 2.E+08 7.E+07 9.E+07 1.E+08 1.E+08 1.E+08 2.E+08 2.E+08 2.E+08 2.E+08 1.E+08 2.E+08 3.E+08 5.E+08 3.E+08 3.E+08 2.E+08 4.E+08 3.E+08 6.E+08 5.E+08 5.E+08 5.E+08 3.E+08 4.E+08 3.E+08 5.E+08 5.E+08 Citrulline 2.E+07 2.E+07 1.E+07 1.E+07 2.E+07 2.E+07 2.E+07 3.E+07 3.E+07 2.E+07 1.E+07 3.E+07 2.E+07 3.E+07 2.E+07 4.E+07 3.E+07 4.E+07 3.E+07 1.E+07 5.E+07 7.E+07 7.E+07 9.E+07 5.E+07 4.E+07 8.E+07 8.E+07 7.E+07 6.E+07 7.E+07 7.E+07 4.E+07 5.E+07 4.E+07 4.E+07 5.E+07 Cys 1.E+06 3.E+06 7.E+05 1.E+06 2.E+06 2.E+06 3.E+06 3.E+06 4.E+06 3.E+06 1.E+06 2.E+06 2.E+06 4.E+06 2.E+06 6.E+06 7.E+06 6.E+06 3.E+06 4.E+06 - - - - - - - - - - - - - - - - - Glu 8.E+08 5.E+08 5.E+08 8.E+08 8.E+08 5.E+08 6.E+08 5.E+08 6.E+08 8.E+08 4.E+08 8.E+08 1.E+09 1.E+09 9.E+08 8.E+08 9.E+08 9.E+08 9.E+08 6.E+08 - - - - - - - - - - - - - - - - - Gln 2.E+09 2.E+09 1.E+09 2.E+09 2.E+09 8.E+08 1.E+09 1.E+09 7.E+08 2.E+09 9.E+08 1.E+09 1.E+09 1.E+09 2.E+09 1.E+09 2.E+09 1.E+09 1.E+09 2.E+09 - - - - - - - - - - - - - - - - - His 5.E+08 5.E+08 3.E+08 4.E+08 6.E+08 2.E+08 3.E+08 4.E+08 3.E+08 4.E+08 3.E+08 4.E+08 5.E+08 5.E+08 5.E+08 5.E+08 5.E+08 4.E+08 3.E+08 4.E+08 - - - - - - - - - - - - - - - - - HomoSer 5.E+07 6.E+07 4.E+07 5.E+07 8.E+07 6.E+07 7.E+07 8.E+07 8.E+07 1.E+08 5.E+07 9.E+07 9.E+07 1.E+08 7.E+07 1.E+08 1.E+08 1.E+08 9.E+07 8.E+07 - - - - - - - - - - - - - - - - - Ile 1.E+08 2.E+08 1.E+08 1.E+08 2.E+08 1.E+08 1.E+08 2.E+08 2.E+08 2.E+08 1.E+08 2.E+08 2.E+08 2.E+08 2.E+08 3.E+08 3.E+08 3.E+08 2.E+08 2.E+08 - - - - - - - - - - - - - - - - - Leu 3.E+08 3.E+08 2.E+08 3.E+08 4.E+08 2.E+08 3.E+08 3.E+08 3.E+08 4.E+08 2.E+08 3.E+08 4.E+08 4.E+08 4.E+08 5.E+08 5.E+08 6.E+08 3.E+08 3.E+08 - - - - - - - - - - - - - - - - - Lys 2.E+08 2.E+08 1.E+08 1.E+08 2.E+08 2.E+08 2.E+08 3.E+08 3.E+08 3.E+08 2.E+08 3.E+08 2.E+08 2.E+08 2.E+08 4.E+08 4.E+08 4.E+08 2.E+08 3.E+08 - - - - - - - - - - - - - - - - - Met 2.E+07 3.E+07 1.E+07 2.E+07 2.E+07 2.E+07 3.E+07 3.E+07 3.E+07 4.E+07 2.E+07 2.E+07 3.E+07 3.E+07 3.E+07 4.E+07 5.E+07 4.E+07 3.E+07 3.E+07 - - - - - - - - - - - - - - - - - Orn 2.E+07 2.E+07 2.E+07 2.E+07 4.E+07 6.E+07 3.E+07 4.E+07 1.E+08 4.E+07 3.E+07 1.E+08 4.E+07 4.E+07 3.E+07 7.E+07 4.E+07 8.E+07 4.E+07 4.E+07 1.E+08 1.E+08 1.E+08 1.E+08 1.E+08 1.E+08 2.E+08 1.E+08 2.E+08 2.E+08 2.E+08 2.E+08 2.E+08 2.E+08 2.E+08 3.E+08 2.E+08 Phe 2.E+08 2.E+08 1.E+08 2.E+08 2.E+08 2.E+08 2.E+08 3.E+08 2.E+08 3.E+08 1.E+08 2.E+08 2.E+08 2.E+08 2.E+08 4.E+08 4.E+08 4.E+08 3.E+08 2.E+08 - - - - - - - - - - - - - - - - - Pro 1.E+08 1.E+08 9.E+07 9.E+07 2.E+08 2.E+08 1.E+08 2.E+08 3.E+08 2.E+08 9.E+07 3.E+08 2.E+08 2.E+08 1.E+08 3.E+08 2.E+08 4.E+08 2.E+08 2.E+08 - - - - - - - - - - - - - - - - - Trp 7.E+07 8.E+07 5.E+07 6.E+07 7.E+07 5.E+07 6.E+07 6.E+07 6.E+07 8.E+07 4.E+07 7.E+07 7.E+07 8.E+07 6.E+07 1.E+08 1.E+08 1.E+08 6.E+07 8.E+07 - - - - - - - - - - - - - - - - - Tyr 6.E+07 9.E+07 5.E+07 7.E+07 7.E+07 6.E+07 7.E+07 6.E+07 7.E+07 1.E+08 4.E+07 8.E+07 8.E+07 6.E+07 8.E+07 1.E+08 1.E+08 1.E+08 9.E+07 9.E+07 - - - - - - - - - - - - - - - - - Val 1.E+08 2.E+08 9.E+07 1.E+08 2.E+08 1.E+08 1.E+08 2.E+08 2.E+08 2.E+08 1.E+08 2.E+08 2.E+08 2.E+08 2.E+08 3.E+08 3.E+08 3.E+08 2.E+08 2.E+08 - - - - - - - - - - - - - - - - - DMG 6.E+07 4.E+07 4.E+07 5.E+07 1.E+08 7.E+07 6.E+07 1.E+08 9.E+07 4.E+07 8.E+07 1.E+08 2.E+08 1.E+08 6.E+07 2.E+08 8.E+07 2.E+08 8.E+07 3.E+07 - - - - - - - - - - - - - - - - - GSSG 8.E+07 6.E+07 4.E+07 5.E+07 5.E+07 1.E+07 2.E+07 3.E+07 1.E+07 3.E+07 3.E+07 4.E+07 6.E+07 9.E+07 3.E+07 5.E+07 6.E+07 5.E+07 4.E+07 4.E+07 - - - - - - - - - - - - - - - - - GSH 2.E+09 3.E+09 1.E+09 2.E+09 2.E+09 1.E+09 1.E+09 1.E+09 1.E+09 2.E+09 2.E+09 2.E+09 3.E+09 2.E+09 2.E+09 2.E+09 2.E+09 2.E+09 2.E+09 2.E+09 - - - - - - - - - - - - - - - - - SAH 2.E+07 2.E+07 1.E+07 2.E+07 2.E+07 9.E+06 8.E+06 1.E+07 1.E+07 7.E+06 2.E+07 3.E+07 3.E+07 3.E+07 1.E+07 1.E+07 1.E+07 2.E+07 9.E+06 9.E+06 2.E+07 6.E+07 5.E+07 4.E+07 2.E+07 2.E+07 4.E+07 3.E+07 1.E+07 1.E+07 2.E+07 2.E+07 1.E+07 1.E+07 1.E+07 1.E+07 1.E+07 SAM 8.E+06 1.E+07 7.E+06 9.E+06 5.E+06 8.E+06 9.E+06 8.E+06 7.E+06 1.E+07 6.E+06 6.E+06 3.E+06 6.E+06 1.E+07 1.E+07 2.E+07 1.E+07 1.E+07 1.E+07 1.E+06 7.E+05 2.E+05 3.E+06 3.E+06 3.E+06 4.E+06 3.E+06 3.E+06 2.E+06 3.E+06 2.E+06 2.E+06 3.E+06 1.E+06 3.E+06 1.E+06 Uracil 4.E+07 3.E+07 2.E+07 2.E+07 3.E+07 3.E+07 4.E+07 3.E+07 3.E+07 3.E+07 2.E+07 3.E+07 4.E+07 3.E+07 3.E+07 3.E+07 4.E+07 5.E+07 3.E+07 3.E+07 - - - - - - - - - - - - - - - - - Uridine 1.E+07 1.E+07 7.E+06 7.E+06 8.E+06 7.E+06 1.E+07 1.E+07 8.E+06 9.E+06 6.E+06 8.E+06 1.E+07 8.E+06 9.E+06 8.E+06 1.E+07 1.E+07 8.E+06 8.E+06 3.E+08 4.E+08 3.E+08 3.E+08 3.E+08 3.E+08 3.E+08 3.E+08 3.E+08 3.E+08 3.E+08 2.E+08 3.E+08 2.E+08 2.E+08 2.E+08 2.E+08 L-Cystathionine 3.E+06 4.E+06 2.E+06 4.E+06 1.E+07 1.E+07 4.E+06 1.E+07 2.E+07 5.E+06 7.E+06 3.E+07 1.E+07 1.E+07 3.E+06 3.E+07 8.E+06 3.E+07 9.E+06 6.E+06 - - - - - - - - - - - - - - - - - Gamma-Glu-Cys 9.E+06 1.E+07 6.E+06 1.E+07 8.E+06 7.E+06 8.E+06 6.E+06 8.E+06 1.E+07 5.E+06 1.E+07 1.E+07 1.E+07 1.E+07 8.E+06 1.E+07 1.E+07 9.E+06 8.E+06 - - - - - - - - - - - - - - - - - 5-Hydroxy-Lys 6.E+05 5.E+05 5.E+05 4.E+05 8.E+05 1.E+06 1.E+06 9.E+05 1.E+06 1.E+06 6.E+05 7.E+05 6.E+05 6.E+05 8.E+05 9.E+05 1.E+06 1.E+06 9.E+05 1.E+06 - - - - - - - - - - - - - - - - - Histamine 3.E+06 1.E+07 9.E+05 2.E+06 3.E+05 1.E+07 1.E+07 1.E+07 3.E+05 3.E+06 1.E+06 5.E+05 6.E+05 5.E+05 8.E+05 1.E+07 9.E+06 1.E+07 1.E+07 6.E+05 - - - - - - - - - - - - - - - - - Xanthine 5.E+07 6.E+07 3.E+07 4.E+07 4.E+07 3.E+07 4.E+07 4.E+07 3.E+07 6.E+07 4.E+07 3.E+07 5.E+07 5.E+07 5.E+07 4.E+07 5.E+07 4.E+07 4.E+07 6.E+07 - - - - - - - - - - - - - - - - - Deoxycytidine 1.E+05 9.E+04 4.E+04 8.E+04 2.E+04 9.E+05 1.E+06 9.E+05 1.E+06 6.E+05 3.E+04 5.E+04 4.E+04 4.E+04 4.E+04 1.E+06 1.E+06 1.E+06 1.E+06 5.E+05 - - - - - - - - - - - - - - - - - Kynurenine 1.E+05 8.E+05 1.E+05 2.E+05 6.E+05 7.E+05 5.E+05 4.E+05 1.E+06 5.E+05 2.E+05 2.E+06 7.E+05 7.E+05 3.E+05 8.E+05 7.E+05 2.E+06 5.E+05 4.E+05 - - - - - - - - - - - - - - - - - Trigonelline 2.E+07 2.E+07 2.E+07 3.E+07 4.E+07 4.E+07 4.E+07 1.E+08 4.E+07 4.E+07 5.E+07 8.E+07 7.E+07 1.E+08 4.E+07 1.E+08 1.E+08 1.E+08 4.E+07 3.E+07 1.E+08 8.E+07 1.E+08 6.E+07 1.E+08 6.E+07 8.E+07 1.E+08 9.E+07 1.E+08 9.E+07 5.E+07 2.E+08 2.E+08 2.E+08 6.E+07 2.E+08 Phosphocholine 1.E+09 7.E+08 6.E+08 5.E+08 1.E+09 8.E+08 1.E+09 2.E+09 1.E+09 7.E+08 1.E+09 1.E+09 1.E+09 1.E+09 7.E+08 2.E+09 2.E+09 2.E+09 1.E+09 8.E+08 - - - - - - - - - - - - - - - - - Beta-Glu 2.E+07 1.E+07 7.E+06 9.E+06 1.E+07 4.E+06 8.E+06 2.E+07 5.E+06 6.E+06 4.E+06 1.E+07 1.E+07 1.E+07 1.E+07 8.E+06 6.E+06 9.E+06 8.E+06 8.E+06 - - - - - - - - - - - - - - - - - Glyceraldehyde 2.E+06 2.E+06 1.E+06 1.E+06 1.E+06 6.E+05 8.E+05 6.E+05 6.E+05 9.E+05 1.E+06 9.E+05 2.E+06 1.E+06 1.E+06 6.E+05 8.E+05 5.E+05 8.E+05 1.E+06 - - - - - - - - - - - - - - - - - Hypotaurine 3.E+07 4.E+07 2.E+07 3.E+07 6.E+07 4.E+07 3.E+07 8.E+07 7.E+07 4.E+07 4.E+07 1.E+08 7.E+07 9.E+07 3.E+07 7.E+07 4.E+07 1.E+08 4.E+07 4.E+07 - - - - - - - - - - - - - - - - - Inosine 1.E+08 1.E+08 8.E+07 8.E+07 9.E+07 4.E+07 6.E+07 6.E+07 4.E+07 9.E+07 9.E+07 6.E+07 1.E+08 1.E+08 1.E+08 7.E+07 7.E+07 6.E+07 6.E+07 1.E+08 - - - - - - - - - - - - - - - - - MSO 1.E+06 2.E+06 1.E+06 1.E+06 2.E+06 2.E+06 2.E+06 3.E+06 3.E+06 2.E+06 1.E+06 5.E+06 2.E+06 2.E+06 1.E+06 3.E+06 3.E+06 4.E+06 2.E+06 1.E+06 - - - - - - - - - - - - - - - - - Succinic anhydride 8.E+06 1.E+07 5.E+06 1.E+07 2.E+07 6.E+06 6.E+06 8.E+06 1.E+07 1.E+07 3.E+06 7.E+06 8.E+06 9.E+06 1.E+07 9.E+06 1.E+07 2.E+07 9.E+06 1.E+07 - - - - - - - - - - - - - - - - - Gamma-Glunolactone 8.E+06 7.E+06 4.E+06 5.E+06 6.E+06 3.E+06 4.E+06 5.E+06 3.E+06 4.E+06 5.E+06 5.E+06 8.E+06 8.E+06 5.E+06 5.E+06 6.E+06 5.E+06 4.E+06 4.E+06 - - - - - - - - - - - - - - - - - NMN 3.E+05 2.E+05 3.E+05 2.E+05 3.E+05 1.E+05 2.E+05 2.E+05 1.E+05 2.E+05 3.E+05 3.E+05 4.E+05 4.E+05 4.E+05 3.E+05 1.E+05 2.E+05 2.E+05 2.E+05 - - - - - - - - - - - - - - - - - Trimethyl-Lys 8.E+06 8.E+06 5.E+06 5.E+06 5.E+06 5.E+06 7.E+06 8.E+06 8.E+06 6.E+06 3.E+06 6.E+06 4.E+06 5.E+06 6.E+06 8.E+06 1.E+07 9.E+06 8.E+06 5.E+06 - - - - - - - - - - - - - - - - - Argininosuccinate 3.E+06 4.E+06 2.E+06 3.E+06 3.E+06 2.E+06 2.E+06 2.E+06 2.E+06 3.E+06 2.E+06 4.E+06 4.E+06 4.E+06 3.E+06 5.E+06 4.E+06 5.E+06 3.E+06 3.E+06 6.E+06 4.E+06 8.E+06 9.E+06 9.E+06 1.E+07 9.E+06 9.E+06 1.E+07 1.E+07 1.E+07 1.E+07 6.E+06 1.E+07 7.E+06 2.E+07 1.E+07 Pyridoxamine 3.E+05 2.E+05 2.E+05 2.E+05 2.E+05 2.E+05 1.E+06 5.E+06 2.E+05 3.E+05 1.E+05 9.E+04 2.E+05 7.E+05 1.E+05 2.E+06 4.E+06 1.E+07 5.E+06 7.E+05 - - - - - - - - - - - - - - - - - 1-Methyl-His 3.E+07 2.E+07 1.E+07 2.E+07 3.E+07 2.E+07 2.E+07 3.E+07 2.E+07 2.E+07 1.E+07 2.E+07 3.E+07 2.E+07 2.E+07 3.E+07 5.E+07 5.E+07 4.E+07 2.E+07 - - - - - - - - - - - - - - - - - Xanthosine 1.E+07 1.E+07 8.E+06 8.E+06 9.E+06 3.E+06 6.E+06 4.E+06 3.E+06 1.E+07 7.E+06 5.E+06 1.E+07 9.E+06 9.E+06 5.E+06 1.E+07 4.E+06 3.E+06 1.E+07 - - - - - - - - - - - - - - - - - Acetylcarnitine 6.E+08 5.E+08 5.E+08 6.E+08 7.E+08 4.E+08 5.E+08 7.E+08 5.E+08 5.E+08 4.E+08 8.E+08 7.E+08 8.E+08 5.E+08 8.E+08 8.E+08 8.E+08 5.E+08 5.E+08 - - - - - - - - - - - - - - - - - Kynurenic acid 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 - - - - - - - - - - - - - - - - - Pyridoxal 1.E+06 1.E+06 7.E+05 1.E+06 1.E+06 1.E+06 2.E+06 3.E+06 9.E+05 1.E+06 7.E+05 6.E+05 1.E+06 1.E+06 9.E+05 2.E+06 2.E+06 5.E+06 3.E+06 9.E+05 - - - - - - - - - - - - - - - - - Homocitrulline 3.E+06 3.E+06 2.E+06 2.E+06 3.E+06 2.E+06 2.E+06 3.E+06 1.E+06 2.E+06 2.E+06 2.E+06 3.E+06 3.E+06 3.E+06 3.E+06 4.E+06 4.E+06 2.E+06 2.E+06 - - - - - - - - - - - - - - - - - Glycerophosphocholine 6.E+08 9.E+08 5.E+08 4.E+08 6.E+08 3.E+08 4.E+08 3.E+08 3.E+08 7.E+08 4.E+08 5.E+08 7.E+08 6.E+08 4.E+08 7.E+08 7.E+08 6.E+08 6.E+08 7.E+08 - - - - - - - - - - - - - - - - - Xanthurenic acid 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 - - - - - - - - - - - - - - - - - N-Acetyl-ornithine 2.E+05 2.E+05 1.E+05 2.E+05 4.E+05 3.E+05 2.E+05 7.E+05 4.E+05 2.E+05 2.E+05 8.E+05 4.E+05 6.E+05 2.E+05 5.E+05 4.E+05 8.E+05 3.E+05 2.E+05 - - - - - - - - - - - - - - - - - Saccharopine 2.E+06 1.E+06 1.E+06 2.E+06 5.E+06 3.E+06 4.E+05 2.E+06 7.E+06 1.E+06 3.E+06 1.E+07 8.E+06 7.E+06 2.E+06 5.E+06 2.E+06 7.E+06 2.E+06 2.E+06 - - - - - - - - - - - - - - - - - L-Anserine 5.E+05 5.E+05 3.E+05 3.E+05 4.E+05 3.E+05 4.E+05 8.E+05 3.E+05 4.E+05 2.E+05 3.E+05 4.E+05 5.E+05 3.E+05 6.E+05 7.E+05 6.E+05 4.E+05 4.E+05 - - - - - - - - - - - - - - - - - N-Acetyl-Lys 2.E+06 2.E+06 8.E+05 1.E+06 2.E+06 9.E+05 1.E+06 2.E+06 1.E+06 1.E+06 1.E+06 2.E+06 2.E+06 2.E+06 2.E+06 2.E+06 2.E+06 3.E+06 1.E+06 1.E+06 - - - - - - - - - - - - - - - - - 3-Hydroxyanthranilic acid 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 - - - - - - - - - - - - - - - - - Gly-Gly 2.E+06 2.E+06 1.E+06 1.E+06 2.E+06 2.E+06 3.E+06 2.E+06 2.E+06 3.E+06 2.E+06 2.E+06 2.E+06 2.E+06 3.E+06 3.E+06 3.E+06 3.E+06 2.E+06 3.E+06 - - - - - - - - - - - - - - - - - Bicine 5.E+05 5.E+05 2.E+05 2.E+05 4.E+05 2.E+05 9.E+04 4.E+05 2.E+05 2.E+05 3.E+05 3.E+05 4.E+05 4.E+05 4.E+05 4.E+05 5.E+05 5.E+05 4.E+05 7.E+05 - - - - - - - - - - - - - - - - - O-Phosphoethanolamine 5.E+07 6.E+07 3.E+07 4.E+07 6.E+07 8.E+07 9.E+07 1.E+08 1.E+08 1.E+08 3.E+07 3.E+07 5.E+07 6.E+07 4.E+07 1.E+08 1.E+08 1.E+08 1.E+08 1.E+08 - - - - - - - - - - - - - - - - - MNAM 1.E+07 1.E+07 8.E+06 1.E+07 1.E+07 2.E+07 3.E+07 4.E+07 2.E+07 2.E+07 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 3.E+07 3.E+07 3.E+07 3.E+07 1.E+08 6.E+07 8.E+07 8.E+07 6.E+07 5.E+07 4.E+07 4.E+07 1.E+08 9.E+07 8.E+07 8.E+07 8.E+07 NAM 1.E+09 1.E+09 5.E+08 7.E+08 8.E+08 6.E+08 7.E+08 8.E+08 6.E+08 7.E+08 8.E+08 8.E+08 1.E+09 9.E+08 9.E+08 1.E+09 9.E+08 1.E+09 8.E+08 8.E+08 4.E+09 5.E+09 4.E+09 4.E+09 4.E+09 4.E+09 5.E+09 4.E+09 3.E+09 3.E+09 3.E+09 3.E+09 3.E+09 2.E+09 2.E+09 2.E+09 2.E+09 NAM ribose 6.E+05 8.E+05 9.E+05 1.E+06 5.E+05 2.E+05 6.E+05 1.E+05 3.E+05 1.E+06 4.E+05 3.E+05 5.E+05 2.E+05 2.E+06 1.E+05 2.E+05 2.E+05 8.E+04 5.E+05 - - - - - - - - - - - - - - - - - 2-py 4.E+06 4.E+06 2.E+06 3.E+06 2.E+06 2.E+06 4.E+06 6.E+06 3.E+06 2.E+06 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 - - - - - - - - - - - - - - - - - 4-py 7.E+06 6.E+06 4.E+06 6.E+06 3.E+06 4.E+06 7.E+06 1.E+07 5.E+06 4.E+06 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 0.E+00 - - - - - - - - - - - - - - - - - N-Formylkynurenine 1.E+05 9.E+04 8.E+04 9.E+04 1.E+05 2.E+04 4.E+04 9.E+04 5.E+04 5.E+04 7.E+04 2.E+05 2.E+05 3.E+05 2.E+05 8.E+04 2.E+05 1.E+05 6.E+04 8.E+04 - - - - - - - - - - - - - - - - - MS_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name 10-Camphorsulfonic acid (IS) PIPES (IS) NAD Suc Adenine Adenosine Beta-Ala Betaine Carnitine Carnosine Choline Creatine Creatinine Cytidine Cytosine GABA Gly Guanine Guanosine 4-Hydroxy-Pro Hypoxanthine Ala Arg Asn Asp Citrulline Cys Glu Gln His HomoSer Ile Leu Lys Met Orn Phe Pro Trp Tyr Val DMG GSSG GSH SAH SAM Uracil Uridine L-Cystathionine Gamma-Glu-Cys 5-Hydroxy-Lys Histamine Xanthine Deoxycytidine Kynurenine Trigonelline Phosphocholine Beta-Glu Glyceraldehyde Hypotaurine Inosine MSO Succinic anhydride Gamma-Glunolactone NMN Trimethyl-Lys Argininosuccinate Pyridoxamine 1-Methyl-His Xanthosine Acetylcarnitine Kynurenic acid Pyridoxal Homocitrulline Glycerophosphocholine Xanthurenic acid N-Acetyl-ornithine Saccharopine L-Anserine N-Acetyl-Lys 3-Hydroxyanthranilic acid Gly-Gly Bicine O-Phosphoethanolamine MNAM NAM NAM ribose 2-py 4-py N-Formylkynurenine METABOLITES_END #END